The award recognises Plewnia's pioneering research on theta burst stimulation (TBS), an innovative and more efficient variant of repetitive transcranial magnetic stimulation (rTMS). With his submitted multicentre phase III study, he has achieved a significant milestone in translational psychiatric research.
The study provides level 1 evidence for a highly effective treatment option for treatment-resistant auditory hallucinations. It exemplifies how basic neuroscientific research can be successfully translated into clinical practice and further developed to directly benefit patients.
A quarter of a century of scientific excellence
For more than 25 years, Plewnia has played a key role in shaping brain stimulation research in Germany. His pioneering work includes the development of bilateral rTMS treatment, its successful translation into clinical application, and the strategic establishment of sustainable research networks. His work impressively demonstrates how innovative neuroscientific methods can sustainably improve the treatment of severe mental illnesses.
Renowned award from the professional association
The DGPPN Prize for Research into Mental Illness honours scientists whose outstanding research and forward-looking concepts are advancing medical progress. The award, which is endowed with a total of 35,000 euros, is presented annually at the DGPPN Congress in Berlin.
Source: Press release from the DGPPN
